Lisdexamfetamine Dimesylate 64850-0553
Product NDC
64850-0553- Manufacturer
- Elite Laboratories, Inc.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- November 15, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA218604
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 40 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 CAPSULE in 1 BOTTLE (64850-553-01)